Scientific Reports · 2018 · 76 citations · 47 references
MedicineCell BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer ProgressionCancer Stem CellsEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionMalignant NeoplasmsOvarian CancerEpithelial-mesenchymal BalanceEpithelial-mesenchymal TransformationEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersMesenchymal TransitionOvarian Cancer MetastasisProtein Expression LevelsTumor Cell Motility
To develop effective therapies for advanced high grade serous ovarian cancer (HGSOC), understanding mechanisms of recurrence and metastasis is necessary. In this study, we define the epithelial/mesenchymal status of cell lines that accurately model HGSOC, and evaluate the therapeutic potential of targeting Snai1 (Snail), a master regulator of the epithelial/mesenchymal transition (EMT) in vitro and in vivo. The ratio of Snail to E-cadherin (S/E index) at RNA and protein levels was correlated with mesenchymal morphology in four cell lines. The cell lines with high S/E index (OVCAR8 and COV318) showed more CSC-like, motile, and chemoresistant phenotypes than those with low S/E index (OVSAHO and Kuramochi). We tested the role of Snail in regulation of malignant phenotypes including stemness, cell motility, and chemotherapy resistance: shRNA-mediated knockdown of Snail reversed these malignant phenotypes. Interestingly, the expression of let-7 tumour suppressor miRNA was upregulated in Snail knockdown cells. Furthermore, knockdown of Snail decreased tumour burden in an orthotopic xenograft mouse model. We conclude that Snail is important in controlling HGSOC malignant phenotypes and suggest that the Snail/Let-7 axis may be an attractive target for HGSOC treatment.
47
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A. Mani, Wenjun Guo, Mai-Jing Liao et al. · Cell · 2008 · 8.7K citations · Full text
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne‐Pierre Morel, Marjory Lièvre, Clémence Thomas et al. · PLoS ONE · 2008 · 1.6K citations · Full text
Medicine, Cancer Biology, Oncology +17